The role of hyaluronic acid in biomineralization

Frontiers of Materials Science

Volumn 6, Issue 4, 2012, Pages 283-296

  Chen, Zhen Hua ^a,b   Ren, Xiu Li ^a   Zhou, Hui Hui ^c   Li, Xu Dong ^b  

^a JINZHOU MEDICAL UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

biomineralization; bone and cartilage repair; crystal growth; extracellular matrix; hyaluronic acid

Indexed keywords

EID: 84870747582     PISSN: 2095025X     EISSN: 20950268     Source Type: Journal    
DOI: 10.1007/s11706-012-0182-4     Document Type: Review

References (142)

1. Ropes M W, Robertson W V B, Rossmeisl E C, et al. Synovial fluid mucin. Acta Medica Scandinavica, 1947, 128(s196): 700-744.
2. Meyer K, Smyth E M, Dawson M H. The isolation of a mucopolysaccharide form synovial fluid. Journal of Biological Chemistry, 1939, 128: 319-327.
3. Meyer K, Palmer J W. The polysaccharide of the vitreous humour. Journal of Biological Chemistry, 1934, 107: 629-634.
4. Ropes M W, Bauer W. Synovial Fluid Changes in Joint Disease. Canbridge MA: Harvard University Press, 1953.
5. Sunblad L. Studies on hyaluronic acid in synovial fluids. Acta Societatis Medicorum Upsaliensis, 1953, 58(3-4): 113-238.
6. Sundblad L. Glycosaminoglycans and glycoproteins in synovial fluid. In: Balazs E A, Jeanloz RW, eds. The Amino Sugars. New York, London: Academic Press, 1964, 229-250.
7. Coleman P J, Scott D, Mason R M, et al. Characterization of the effect of high molecular weight hyaluronan on trans-synovial flow in rabbit knees. The Journal of Physiology, 1999, 514(1): 265-282.
8. Blumberg B S, Ogston A G. Physicochemical studies on hyaluronic acid. In: Chemistry and Biology Mucopolysaccharides (Ciba Foundation Symposium). London: Churchill, 1953, 22-37.
9. Balazs E A. Physical chemistry of hyaluronic acid. Federation Proceedings, 1958, 17(4): 1086-1093.
10. Almond A, Sheehan J K, Brass A. Molecular dynamics simulations of the two disaccharides of hyaluronan in aqueous solution. Glycobiology, 1997, 7(5): 597-604.
11. Almond A, Brass A, Sheehan J K. Dynamic exchange between stabilized conformations predicted for hyaluronan tetrasaccharides: comparison of molecular dynamics simulations with available NMR data. Glycobiology, 1998, 8(10): 973-980.
12. Almond A, Brass A, Sheehan J K. Oligosaccharides as model systems for understanding water-biopolymer interaction: hydrated dynamics of a hyaluronan decamer. Journal of Physical Chemistry B, 2000, 104(23): 5634-5640.
13. Almond A, Brass A, Sheehan J K. Deducing polymeric structure from aqueous molecular dynamics simulations of oligosaccharides: predictions from simulations of hyaluronan tetrasaccharides compared with hydrodynamic and X-ray fibre diffraction data. Journal of Molecular Biology, 1998, 284(5): 1425-1437.
14. Toole B P. Hyaluronan: from extracellular glue to pericellular cue. Nature Reviews Cancer, 2004, 4(7): 528-539.
15. Sutherland I W. Novel and established applications of microbial polysaccharides. Trends in Biotechnology, 1998, 16(1): 41-46.
16. Morimoto K, Yamaguchi H, Iwakura Y, et al. Effects of viscous hyaluronate-sodium solutions on the nasal absorption of vasopressin and an analogue. Pharmaceutical Research, 1991, 8(4): 471-474.
17. Luo Y, Ziebell M R, Prestwich G D. A hyaluronic acid-taxol antitumor bioconjugate targeted to cancer cells. Biomacromolecules, 2000, 1(2): 208-218.
18. Adams M E. Viscosupplementation: a treatment for osteoarthritis. Journal of Rheumatology, 1993, 20(s39): 1-24.
19. Han S Y, Han H S, Lee S C, et al. Mineralized hyaluronic acid nanoparticles as a robust drug carrier. Journal of Materials Chemistry, 2011, 21(22): 7996-8001.
20. Chen Z H, Zhou H H, Wang X L, et al. Controlled mineralization by extracellular matrix: monodisperse, colloidally stable calcium phosphate-hyaluronan hybrid nanospheres. Chemical Communications, 2010, 46(8): 1278-1280.
21. Chen Z H, Wang C H, Zhou H H, et al. Biomimetic crystallization of toplike calcite single crystals with an extensive (00. 1) face in the presence of sodium hyaluronate. Crystal Growth & Design, 2010, 10(11): 4722-4727.
22. Chen Z H, Wang C H, Zhou H H, et al. Modulation of calcium oxalate crystallization by commonly consumed green tea. CrystEngComm, 2010, 12(3): 845-852.
23. Hou S, Xu Q, Tian W, et al. The repair of brain lesion by implantation of hyaluronic acid hydrogels modified with laminin. Journal of Neuroscience Methods, 2005, 148(1): 60-70.
24. Ren Y J, Zhou Z Y, Cui F Z, et al. Hyaluronic acid/polylysine hydrogel as a transfer system for transplantation of neural stem cells. Journal of Bioactive and Compatible Polymers, 2009, 24(1): 56-62.
25. Hardingham T E, Muir H. The specific interaction of hyaluronic acid with cartillage proteoglycans. Biochimica et Biophysica Acta, 1972, 279(2): 401-405.
26. Huang L, Cheng Y Y, Koo P L, et al. The effect of hyaluronan on osteoblast proliferation and differentiation in rat calvarial-derived cell cultures. Journal of Biomedical Materials Research Part A, 2003, 66A(4): 880-884.
27. Fraser J R E, Laurent T C, Laurent U B G. Hyaluronan: its nature, distribution, functions and turnover. Journal of Internal Medicine, 1997, 242(1): 27-33.
28. Laurent T C, Fraser J R. Hyaluronan. FASEB Journal, 1992, 6(7): 2397-2404.
29. Lowenstam H A, Weiner S. On Biomineralization. Oxford: Oxford University Press, 1989, 324.
30. Mann S, Webb J, Williams R J P. Biomineralization. Weinheim: VCH, 1989, 490.
31. Simkiss K, Wilbur K M. Biomineralization. San Diego, CA: Academic Press, 1989, 337.
32. Baeuerlein E. Biomineralization. Weinheim: Wiley-VCH, 2000, 294.
33. Mann S. Biomineralization. Oxford: Oxford University Press, 2001, 198.
34. Baeuerlein E. Handbook of Biomineralization. Biological Aspects and Structure Formation. Weinheim: Wiley-VCH, 2007, 440.
35. Arias J L, Fernandez MS. Biomineralization: From Paleontology to Materials Science. Santiago, Chile: Editorial Universitaria, 2007, 534.
36. Dorozhkin S V, Epple M. Biological and medical significance of calcium phosphates. Angewandte Chemie International Edition, 2002, 41(17): 3130-3146.
37. LeGeros R Z. In: Brown P W, Constantz B, eds. Hydroxyapatite and Related Materials. Boca Raton, FL: CRC, 1994, 3-28.
38. Rueger J M. Bone substitution materials. Current status and prospects. Der Orthopade, 1998, 27(2): 72-79.
39. LeGeros R Z, LeGeros J P. In: Schnettler R, Markgraf E, eds. Knochenersatzmaterialien und wachstumsfaktoren. Stuttgart: Thieme, 1997, 180 (in German).
40. Choi J S, Köller M, Müller D, et al. Verbesserung der biokompatibilität von Ni-Ti-Formgedächtnislegierungen ("Nitinol") durch beschichtung mit calciumphosphaten aus lösung. Biomedizinische Technik, 2001, 46(s1): 226-227 (in German).
41. Ambard A J, Mueninghoff L. Calcium phosphate cement: review of mechanical and biological properties. Journal of Prosthodontics, 2006, 15(5): 321-328.
42. Saha S, Pal S. Mechanical properties of bone cement: a review. Journal of Biomedical Materials Research, 1984, 18(4): 435-462.
43. Gisep A, Wieling R, Bohner M, et al. Resorption patterns of calcium-phosphate cements in bone. Journal of Biomedical Materials Research Part A, 2003, 66A(3): 532-540.
44. Morejón-Alonso L, Ferreira O J B, Carrodeguas R G, et al. Bioactive composite bone cement based on α-tricalcium phosphate/tricalcium silicate. Journal of Biomedical Materials Research Part B: Applied Biomaterials, 2012, 100B(1): 94-102.
45. Brunner T J, Grass R N, Bohner M, et al. Effect of particle size, crystal phase and crystallinity on the reactivity of tricalcium phosphate cements for bone reconstruction. Journal of Materials Chemistry, 2007, 17(38): 4072-4078.
46. Henslee A M, Gwak D-H, Mikos A G, et al. Development of a biodegradable bone cement for craniofacial applications. Journal of Biomedical Materials Research Part A, 2012, 100A(9): 2252-2259.
47. James R, Deng M, Laurencin C T, et al. Nanocomposites and bone regeneration. Frontier of Materials Science, 2011, 5(4): 342-357.
48. Cui F Z, Wen H B, Su X W, et al. Microstructures of external periosteal callus of repaired femoral fracture in children. Journal of Structural Biology, 1996, 117(3): 204-208.
49. Zhang W, Liao S S, Cui F Z. Hierarchical self-assembly of nanofibrils in mineralized collagen. Chemistry of Materials, 2003, 15(16): 3221-3226.
50. Zhang W, Huang Z L, Liao S S, et al. Nucleation sites of calcium phosphate crystals during collagen mineralization. Journal of the American Ceramic Society, 2003, 86(6): 1052-1054.
51. Cui F-Z, Li Y, Ge J. Self-assembly of mineralized collagen composites. Materials Science and Engineering R: Reports, 2007, 57(1-6): 1-27.
52. Cai Y, Liu Y, Yan W, et al. Role of hydroxyapatite nanoparticle size in bone cell proliferation. Journal of Materials Chemistry, 2007, 17(36): 3780-3787.
53. Bakoš D, Soldán M, Hernández-Fuentes I. Hydroxyapatite-collagen-hyaluronic acid composite. Biomaterials, 1999, 20(2): 191-195.
54. Solchaga L A, Dennis J E, Goldberg VM, et al. Hyaluronic acidbased polymers as cell carriers for tissue-engineered repair of bone and cartilage. Journal of Orthopaedic Research, 1999, 17(2): 205-213.
55. Aebli N, Stich H, Schawalder P, et al. Effects of bone morphogenetic protein-2 and hyaluronic acid on the osseointegration of hydroxyapatite-coated implants: an experimental study in sheep. Journal of Biomedical Materials Research Part A, 2005, 73A(3): 295-302.
56. Yoshikawa M, Tsuji N, Toda T, et al. Osteogenic effect of hyaluronic acid sodium salt in the pores of a hydroxyapatite scaffold. Materials Science and Engineering C, 2007, 27(2): 220-226.
57. Ishikawa Y, Komotori J, Senna M. Properties of hydroxyapatitehyaluronic acid nano-composite sol and its interaction with natural bones and collagen fibers. Current Nanoscience, 2006, 2(3): 191-196.
58. Shen H, Tan J, Saltzman W M. Surface-mediated gene transfer from nanocomposites of controlled texture. Nature Materials, 2004, 3(8): 569-574.
59. Maitra A. Calcium phosphate nanoparticles: second-generation nonviral vectors in gene therapy. Expert Review of Molecular Diagnostics, 2005, 5(6): 893-905.
60. Sokolova V, Epple M. Inorganic nanoparticles as carriers of nucleic acids into cells. Angewandte Chemie International Edition, 2008, 47(8): 1382-1395.
61. Sokolova V V, Radtke I, Heumann R, et al. Effective transfection of cells with multi-shell calcium phosphate-DNA nanoparticles. Biomaterials, 2006, 27(16): 3147-3153.
62. Chowdhury E H, Kutsuzawa K, Akaike T. Designing smart nano-apatite composites: the emerging era of non-viral gene delivery. Gene Therapy & Molecular Biology, 2005, 9: 301-315.
63. Sokolova V, Kovtun A, Prymak O, et al. Functionalisation of calcium phosphate nanoparticles by oligonucleotides and their application for gene silencing. Journal of Materials Chemistry, 2007, 17(8): 721-727.
64. Pedraza C E, Bassett D C, McKee M D, et al. The importance of particle size and DNA condensation salt for calcium phosphate nanoparticle transfection. Biomaterials, 2008, 29(23): 3384-3392.
65. Kakizawa Y, Miyata K, Furukawa S, et al. Size-controlled formation of a calcium phosphate-based organic-inorganic hybrid vector for gene delivery using poly(ethylene glycol)-block-poly(aspartic acid). Advanced Materials, 2004, 16(8): 699-702.
66. Welzel T, Radtke I, Meyer-Zaika W, et al. Transfection of cells with custom-made calcium phosphate nanoparticles coated with DNA. Journal of Materials Chemistry, 2004, 14(14): 2213-2217.
67. Donners J J J M, Nolte R J M, Sommerdijk N A J M. Dendrimerbased hydroxyapatite composites with remarkable materials. Advanced Materials, 2003, 15(4): 313-316.
68. Shkilnyy A, Friedrich A, Tiersch B, et al. Poly(ethylene imine)-controlled calcium phosphate mineralization. Langmuir, 2008, 24(5): 2102-2109.
69. Schmidt H T, Gray B L, Wingert P A, et al. Assembly of aqueous-cored calcium phosphate nanoparticles for drug delivery. Chemistry of Materials, 2004, 16(24): 4942-4947.
70. Sauer M, Haefele T, Graff A, et al. Ion-carrier controlled precipitation of calcium phosphate in giant ABA triblock copolymer vesicles. Chemical Communications, 2001, 23(23): 2452-2453.
71. Sugawara A, Yamane S, Akiyoshi K. Nanogel-templated mineralization: polymer-calcium phosphate hybrid nanomaterials. Macromolecular Rapid Communications, 2006, 27(6): 441-446.
72. Perkin K K, Turner J L, Wooley K L, et al. Fabrication of hybrid nanocapsules by calcium phosphate mineralization of shell crosslinked polymer micelles and nanocages. Nano Letters, 2005, 5(7): 1457-1461.
73. Ethirajan A, Ziener U, Chuvilin A, et al. Biomimetic hydroxyapatite crystallization in gelatin nanoparticles synthesized using a miniemulsion process. Advanced Functional Materials, 2008, 18(15): 2221-2227.
74. Wang X, Zhuang J, Peng Q, et al. Liquid-solid-solution synthesis of biomedical hydroxyapatite nanorods. Advanced Materials, 2006, 18(15): 2031-2034.
75. Antonietti M, Breulmann M, Göltner C G, et al. Inorganic/organic mesostructures with complex architectures: precipitation of calcium phosphate in the presence of double-hydrophilic block copolymers. Chemistry - A European Journal, 1998, 4(12): 2493-2500.
76. Song R Q, Xu A W, Antonietti M, et al. Calcite crystals with platonic shapes and minimal surfaces. Angewandte Chemie International Edition, 2009, 48(2): 395-399.
77. Han S, Han H S, Lee S C, et al. Mineralized hyaluronic acid nanoparticles as a robust drug carrier. Journal of Materials Chemistry, 2011, 21(22): 7996-8001.
78. Furth G, Knierim R, Buss V, et al. Binding of bivalent cations by hyaluronate in aqueous solution. International Journal of Biological Macromolecules, 2008, 42(1): 33-40.
79. Scott J E, Heatley F. Hyaluronan forms specific stable tertiary structures in aqueous solution: a 13C NMR study. Proceedings of the National Academy of Sciences of the United States of America, 1999, 96(9): 4850-4855.
80. Lippmann F. Sedimentary Carbonate Minerals. Berlin: Springer-Verlag, 1973.
81. Orme C A, Noy A, Wierzbicki A, et al. Formation of chiral morphologies through selective binding of amino acids to calcite surface steps. Nature, 2001, 411(6839): 775-779.
82. Fu G, Qiu S R, Orme C A, et al. Acceleration of calcite kinetics by abalone nacre proteins. Advanced Materials, 2005, 17(22): 2678-2683.
83. Kulp E A, Switzer J A. Electrochemical biomineralization: the deposition of calcite with chiral morphologies. Journal of the American Chemical Society, 2007, 129(49): 15120-15121.
84. Huang Y X, Buder J, Cardoso-Gil R, et al. Shape development and structure of a complex (otoconia-like?) calcite-gelatine composite. Angewandte Chemie International Edition, 2008, 47(43): 8280-8284.
85. Weissbuch I, Addadi L, Leiserowitz L. Molecular recognition at crystal interfaces. Science, 1991, 253(5020): 637-645.
86. Wolf S E, Loges N, Mathiasch B, et al. Phase selection of calcium carbonate through the chirality of adsorbed amino acids. Angewandte Chemie International Edition, 2007, 46(29): 5618-5623.
87. 3 crystals with amino acids. Angewandte Chemie International Edition, 2008, 47(20): 3680-3682.
88. 3 crystals with amino acids. Angewandte Chemie International Edition, 2008, 47(20): 3683-3686.
89. 3 crystals in the presence of a polyelectrolyte additive. Journal of the American Chemical Society, 2005, 127(10): 3246-3247.
90. Wang T X, Antonietti M, Cölfen H. Calcite mesocrystals: "morphing" crystals by a polyelectrolyte. Chemistry - A European Journal, 2006, 12(22): 5722-5730.
91. 3 (zabuyelite) anomalous mixed crystals. Sector zoning and growth mechanisms. Crystal Growth & Design, 2008, 8(9): 3451-3460.
92. Rajam S, Mann S. Selective stabilization of the (001) face of calcite in the presence of lithium. Journal of the Chemical Society: Chemical Communications, 1990, 24(24): 1789-1791.
93. + ions. Surface behavior of the {0001} form. Crystal Growth & Design, 2004, 4(3): 485-490.
94. Arias J L, Neira-Carrillo A, Arias J I, et al. Sulfated polymers in biological mineralization: a plausible source for bio-inspired engineering. Journal of Materials Chemistry, 2004, 14(14): 2154-2160.
95. Arias J L, Fernández M S. Polysaccharides and proteoglycans in calcium carbonate-based biomineralization. Chemical Reviews, 2008, 108(11): 4475-4482.
96. Chen Z H, Chen J Z, Li X D, et al. Unpublished work.
97. Yu H, Sheikholeslami R, Doherty W O S. The effects of silica and sugar on the crystallographic and morphological properties of calcium oxalate. Journal of Crystal Growth, 2004, 265(3-4): 592-603.
98. Grases F, García-Ferragut L, Söhnel O, et al. Study on calcium oxalate monohydrate renal uroliths I. Qualitative properties. Scandinavian Journal of Urology and Nephrology, 1995, 29(4): 413-419.
99. Demadis K D. In: Shah R K, ed. Compact Heat Exchangers and Enhancement Technology for the Process Industries. New York: Begell House Inc., 2003, 483-490.
100. Aki{dotless}n B, Öner M, Bayram Y, et al. Effects of carboxylatemodified, "green" inulin biopolymers on the crystal growth of calcium oxalate. Crystal Growth & Design, 2008, 8(6): 1997-2005.
101. Millan A. Crystal growth shape of whewellite polymorphs: Influence of structure distortions on crystal shape. Crystal Growth & Design, 2001, 1(3): 245-254.
102. Wesson J A, Worcester E M, Kleinman J G. Role of anionic proteins in kidney stone formation: interaction between model anionic polypeptides and calcium oxalate crystals. Journal of Urology, 2000, 163(4): 1343-1348.
103. Joshi V S, Parekh B B, Joshi MJ, et al. Herbal extracts of tribulus terrestris and bergenia ligulata inhibit growth of calcium oxalate monohydrate crystals in vitro. Journal of Crystal Growth, 2005, 275(1-2): e1403-e1408.
104. Li X, Zhang D, Lynch-Holm V J, et al. Isolation of a crystal matrix protein associated with calcium oxalate precipitation in vacuoles of specialized cells. Plant Physiology, 2003, 133(2): 549-559.
105. Backov R, Lee C M, Khan S R, et al. Calcium oxalate monohydrate precipitation at phosphatidylglycerol Langmuir monolayers. Langmuir, 2000, 16(14): 6013-6019.
106. Ouyang J M, Deng S P, Zhou N, et al. Effect of tartrates with various counterions on the precipitation of calcium oxalate in vesicle solutions. Colloids and Surfaces A: Physicochemical and Engineering Aspects, 2005, 256(1): 21-27.
107. Skrtić D, Filipović-Vinceković N, Babić-Ivančić V, et al. Influence of sodium cholate on the crystallization of calcium oxalate. Journal of Crystal Growth, 1993, 133(3-4): 189-195.
108. Weaver M L, Qiu S R, Hoyer J R, et al. Inhibition of calcium oxalate monohydrate growth by citrate and the effect of the background electrolyte. Journal of Crystal Growth, 2007, 306(1): 135-145.
109. Jung T, Sheng X, Choi C K, et al. Probing crystallization of calcium oxalate monohydrate and the role of macromolecule additives with in situ atomic force microscopy. Langmuir, 2004, 20(20): 8587-8596.
110. Guo S, Ward M D, Wesson J A. Direct visualization of calcium oxalate monohydrate crystallization and dissolution with atomic force microscopy and the role of polymeric additives. Langmuir, 2002, 18(11): 4284-4291.
111. Akyol E, Bozkurt A, Öner M. The effects of polyelectrolytes on the inhibition and aggregation of calcium oxalate crystallization. Polymers for Advanced Technologies, 2006, 17(1): 58-65.
112. Akyol E, Öner M. Inhibition of calcium oxalate monohydrate crystal growth using polyelectrolytes. Journal of Crystal Growth, 2007, 307(1): 137-144.
113. Wang L, Qiu S R, Zachowicz W, et al. Modulation of calcium oxalate crystallization by linear aspartic acid-rich peptides. Langmuir, 2006, 22(17): 7279-7285.
114. Wesson J A, Worcester E M, Wiessner J H, et al. Control of calcium oxalate crystal structure and cell adherence by urinary macromolecules. Kidney International, 1998, 53(4): 952-957.
115. Sallis J D, Lumley M F. On the possible role of glycosaminoglycans as natural inhibitors of calcium oxalate stones. Investigative Urology, 1979, 16(4): 296-299.
116. Nishio S, Abe Y, Wakatsuki A, et al. Matrix glycosaminoglycan in urinary stones. Journal of Urology, 1985, 134(3): 503-505.
117. Angell A H, Resnick M I. Surface interaction between glycosaminoglycans and calcium oxalate. Journal of Urology, 1989, 141(5): 1255-1258.
118. Asselman M, Verhulst A, De Broe M E, et al. Calcium oxalate crystal adherence to hyaluronan-, osteopontin-, and CD44-expressing injured/regenerating tubular epithelial cells in rat kidneys. Journal of the American Society of Nephrology, 2003, 14(12): 3155-3166.
119. Coe F L, Evan A P, Worcester E M, et al. Three pathways for human kidney stone formation. Urological Research, 2010, 38(3): 147-160.
120. Verkoelen C F. Crystal retention in renal stone disease: a crucial role for the glycosaminoglycan hyaluronan? Journal of the American Society of Nephrology, 2006, 17(6): 1673-1687.
121. Asselman M, Williams J C, Evan A P, et al. Hyaluronan and stone disease. AIP Conference Proceedings, 2008, 1049: 133-144.
122. Jonassen J A, Cao L C, Honeyman T, et al. Intracellular events in the initiation of calcium oxalate stones. Nephron Experimental Nephrology, 2004, 98(2): e61-e64.
123. Ratkalkar V N, Kleinman J G. Mechanisms of stone formation. Clinical Reviews in Bone and Mineral Metabolism, 2011, 9(3-4): 187-197.
124. Khan S R, Kok D J. Modulators of urinary stone formation. Frontiers in Bioscience, 2004, 9(1-3): 1450-1482.
125. Khan S R. Role of renal epithelial cells in the initiation of calcium oxalate stones. Nephron Experimental Nephrology, 2004, 98(2): e55-e60.
126. Basavaraj D R, Biyani C S, Browning A J, et al. The role of urinary kidney stone inhibitors and promoters in the pathogenesis of calcium containing renal stones. EAU-EBU Update Series, 2007, 5(3): 126-136.
127. Schepers M S J, van der Boom B G, Romijn J C, et al. Urinary crystallization inhibitors do not prevent crystal binding. The Journal of Urology, 2002, 167(4): 1844-1847.
128. Knepper M A, Saidel G M, Hascall V C, et al. Concentration of solutes in the renal inner medulla: interstitial hyaluronan as a mechano-osmotic transducer. American Journal of Physiology-Renal Physiology, 2003, 284(3): F433-F446.
129. Hautmann R, Lehmann A, Komor S. Calcium and oxalate concentrations in human renal tissue: the key to the pathogenesis of stone formation? The Journal of Urology, 1980, 123(3): 317-319.
130. Verkoelen C F, van Der Boom B G, Romijn J C. Identification of hyaluronan as a crystal-binding molecule at the surface of migrating and proliferating MDCK cells. Kidney International, 2000, 58(3): 1045-1054.
131. Niemeyer C M, Mirkin C A. Nanobiotechnology. Weinheim: Wiley-VCH, 2004.
132. Lee H, Choi S H, Park T G. Direct visualization of hyaluronic acid polymer chain by self-assembled one-dimensional array of gold nanoparticles. Macromolecules, 2006, 39(1): 23-25.
133. Jeong Y I, Kim S T, Jin S G, et al. Cisplatin-incorporated hyaluronic acid nanoparticles based on ion-complex formation. Journal of Pharmaceutical Sciences, 2008, 97(3): 1268-1276.
134. Kumar A, Sahoo B, Montpetit A, et al. Development of hyaluronic acid-Fe2O3 hybrid magnetic nanoparticles for targeted delivery of peptides. Nanomedicine: Nanotechnology, Biology and Medicine, 2007, 3(2): 132-137.
135. Lee Y, Lee H, Kim Y B, et al. Bioinspired surface immobilization of hyaluronic acid on monodisperse magnetite nanocrystals for targeted cancer imaging. Advanced Materials, 2008, 20(21): 4154-4157.
136. Laroui H, Grossin L, Léonard M, et al. Hyaluronate-covered nanoparticles for the therapeutic targeting of cartilage. Biomacromolecules, 2007, 8(12): 3879-3885.
137. Mendes R M, Silva G A B, Caliari M V, et al. Effects of single wall carbon nanotubes and its functionalization with sodium hyaluronate on bone repair. Life Sciences, 2010, 87(7-8): 215-222.
138. Kim J, Park K, Hahn S K. Effect of hyaluronic acid molecular weight on the morphology of quantum dot-hyaluronic acid conjugates. International Journal of Biological Macromolecules, 2008, 42(1): 41-45.
139. Bhang S H, Won N, Lee T J, et al. Hyaluronic acid-quantum dot conjugates for in vivo lymphatic vessel imaging. ACS Nano, 2009, 3(6): 1389-1398.
140. Erathodiyil N, Ying J Y. Functionalization of inorganic nanoparticles for bioimaging applications. Accounts of Chemical Research, 2011, 44(10): 925-935.
141. Cao M-R, Hou J, Zhang Q, et al. Preparation of hyaluronic acidquantum dot conjugate and its application in tumor imaging. Chemical Journal of Chinese Universities, 2012, 33(03): 437-441.
142. Stadlinger B, Hintze V, Bierbaum S, et al. Biological functionalization of dental implants with collagen and glycosaminoglycans - A comparative study. Journal of Biomedical Materials Research Part B: Applied Biomaterials, 2012, 100B(2): 331-341.